• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
    • Supply Chain
    • AI and Machine Learning
  • Awards
    • Outsourcing Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Mounjaro

Paris France
Marketing

French regulator fines Novo, Lilly over obesity drug promotion

As Novo Nordisk and Eli Lilly’s rivalry heats up, French regulators are reminding the two obesity drugmakers what happens when promotion goes too far.
Ben Adams May 6, 2026 9:40am
Lebanon Eli Lilly Lebanon

Lilly’s U.S investment splurge continues with added $4.5B pledge

May 6, 2026 9:00am
Eli Lilly Lilly

Lilly stands behind strength of early Foundayo launch

Apr 30, 2026 11:42am
Blue background with repeated three-dimensional dollar-sign shapes and the words The Top Line in red and white at the b

Pulse check on Lilly's GLP-1 fortunes

Mar 27, 2026 9:00am
Eli Lilly Lilly

Lilly warns of 'impurity' in some compounded tirzepatide drugs

Mar 12, 2026 10:00am
David Ricks Lilly CEO Eli Lilly CEO

Lilly CEO David Ricks collects $36.7M pay package for 2025

Mar 9, 2026 3:20pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2026 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings